2nd Quarter - Report

GENENTECH, INC for GENENTECH INC

Firm
Client
Income
—
Expenses
$1,333,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

Labor HHS Appropriations - S. 3230 and H.R. 3042 Homeland Security Appropriations S.3181 and H.R. 6947

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Veterans Affairs, Dept of (VA); SENATE; Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA)

Bills named: H.R. 3042 (111th), S. 3230 (111th), H.R. 6947 (111th), S. 3181 (111th)

Food Industry (safety, labeling, etc.) FOO

Monitor food safety and supply chain issues

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Executive Office of the President (EOP); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); SENATE; Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

Monitor issues related to export rules and regulations International patent issues WTO matters and other international trade issues impacting biotech and pharmaceuticals

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: SENATE; Veterans Affairs, Dept of (VA); Centers For Medicare and Medicaid Services (CMS); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM)

Taxation/Internal Revenue Code TAX

Monitor and report on corporate tax issues; Monitoring proposals on U.S. tax treatment of foreign corporations; S. 506, Stop Tax Haven Abuse Act;

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA)

Bills named: S. 506 (111th)

Copyright/Patent/Trademark CPT

Patent Settlement Issues; Intellectual Property and Process Patent Issues; H.R. 1908; S. 515 & HR. 1260 - Patent Reform Act of 2009; Monitor legislation regarding brand name and generic pharmaceutical agreement, patent fees, and post-grant review reforms.

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: SENATE; Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS)

Bills named: S. 515 (111th), H.R. 1908 (111th), H.R. 1260 (111th)

Health Issues HCR

Pandemic Preparedeness: Tamiflu; Advocate on legislative changes in the health care reform bill regarding biosimilars; Monitor changes to outpatient 340B presecription drug discount program, including related provisions included in HR 4213 - American Jobs and Closing Tax Loopholes Act, and ddraft Senate amendments to the legislation; Labor, Health and Human Services Appropriations bill; H.R. 1548 - Pathway for Biosimilars Act; Health care and biotechnology legislation, including H.R. 3490; Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010", including comparative effectiveness provisions; S. 726/H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; H.R. 1548 - Pathway for Biosimilars Act; Physician payment disclosure including S. 301; Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for Americans Act; H.R. 3590; Patient Protection and Affordable Care Act H.R. 4872, the Reconciliation Act of 2010; Follow on biologics includuing H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Savings Medicines Act; H.R. 3962, Affordable health care for America Act; Comparative effectiveness legislation including S. 1213; Patient-Centered Outcomes Research Act of 2009; H.R. 3200, America's Health Future Act; H.R. 1548 - Pathway for Dissimilar Act; Legislative changes in the heatlh care reform bill regarding dissimilars; S. 1679 Affordeable Health Choice Act; S.1796, America's Health future Act of 2009; Pharmacuetical import safety legislation. H.R. 1105 Omnibus Appropriations Act of 2010; Supplemental Appropriations Act of 2010, Food Safety Issues concerning clinlical trials; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 H.R. 3590 Patient Protetion and Affordable Care Act - FTC issue Ryan White CARE Act reauthorization

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: SENATE; Executive Office of the President (EOP); Veterans Affairs, Dept of (VA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS)

Bills named: S. 726 (111th), H.R. 1548 (111th), H.R. 3974 (111th), S. 1679 (111th), H.R. 3490 (111th), H.R. 3590 (111th), H.R. 4872 (111th), H.R. 154 (111th), H.R. 3962 (111th), S. 301 (111th), H.R. 1427 (111th), H.R. 4213 (111th), S. 1796 (111th), H.R. 3200 (111th), S. 1213 (111th), H.R. 1105 (111th)

Medicare/Medicaid MMM

Monitor implementation of Medicare pharmaceutical coverage and reimbusement provisions of P.L. 111-148 - Patient protection and Affordable CAre Act and P.L. 111-152 - Health Care and Education Reconciliation Act; Implementation of H.R. 1; Medicare Prescription Drug and Modernization Act of 2003; Medicare and Medicaid Coverage and Reimbursement; issues relating to Prescription Drug User Fee Act, stimulus provisions and economic recovery; Issues related to comparative effectiveness and follow-on biologics; H.R. 3200 and America's health Future Act of 2009; H.R. 4213, the American jobs, Closing Tax Loopholes and Preventing Outsourcing Act of 2010 - eligibility changes for the 340B program, treatment of certain drugs for computation of Average Manufacturer's Price under the Medicaid program; Participatd in discussions with Senate Aging Comm staff on Medicare coverage payment issues related to cancer biotherapeutics;

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Homeland Security, Dept of (DHS); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 3200 (111th), H.R. 4213 (111th), H.R. 1 (111th)

Budget/Appropriations BUD

Following issues related to the budget and appropriations process; Issues related to government purchases of pandemic drugs: Tamiflu; Seek Federal appropriations in the FY11 Labor, Health and Human Services and Education bill regarding pandemic influenza;HIV/AIDS programs and HCV screening, care and treatment; Implementation of H.R. 2346, S. 10554; FY09 Supplemental Appropriations related to preparedness for pandemic influenza; FY11 State Foreign Operations appropriations related to USAID and funding for Pandemic Influenza

LobbyistCovered position, as disclosed
DAVID B BURT —
DARIN GARDNER —
ANNA GRIFFIN —
EVAN MORRIS —
KATHERINE RAAB —

Contacted: Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); SENATE; Veterans Affairs, Dept of (VA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 10554 (111th), H.R. 2346 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.